全文获取类型
收费全文 | 5085篇 |
免费 | 597篇 |
国内免费 | 29篇 |
专业分类
耳鼻咽喉 | 34篇 |
儿科学 | 145篇 |
妇产科学 | 67篇 |
基础医学 | 623篇 |
口腔科学 | 241篇 |
临床医学 | 648篇 |
内科学 | 1036篇 |
皮肤病学 | 58篇 |
神经病学 | 361篇 |
特种医学 | 405篇 |
外科学 | 743篇 |
综合类 | 84篇 |
预防医学 | 606篇 |
眼科学 | 94篇 |
药学 | 197篇 |
中国医学 | 1篇 |
肿瘤学 | 368篇 |
出版年
2023年 | 60篇 |
2022年 | 35篇 |
2021年 | 35篇 |
2020年 | 65篇 |
2019年 | 71篇 |
2018年 | 112篇 |
2017年 | 79篇 |
2016年 | 96篇 |
2015年 | 101篇 |
2014年 | 171篇 |
2013年 | 233篇 |
2012年 | 208篇 |
2011年 | 210篇 |
2010年 | 142篇 |
2009年 | 169篇 |
2008年 | 206篇 |
2007年 | 225篇 |
2006年 | 184篇 |
2005年 | 191篇 |
2004年 | 185篇 |
2003年 | 140篇 |
2002年 | 147篇 |
2001年 | 167篇 |
2000年 | 162篇 |
1999年 | 164篇 |
1998年 | 130篇 |
1997年 | 128篇 |
1996年 | 121篇 |
1995年 | 94篇 |
1994年 | 95篇 |
1993年 | 81篇 |
1992年 | 87篇 |
1991年 | 91篇 |
1990年 | 105篇 |
1989年 | 103篇 |
1988年 | 97篇 |
1987年 | 97篇 |
1986年 | 102篇 |
1985年 | 99篇 |
1984年 | 62篇 |
1983年 | 49篇 |
1982年 | 49篇 |
1981年 | 62篇 |
1980年 | 40篇 |
1979年 | 61篇 |
1978年 | 41篇 |
1977年 | 43篇 |
1976年 | 46篇 |
1975年 | 32篇 |
1973年 | 31篇 |
排序方式: 共有5711条查询结果,搜索用时 15 毫秒
11.
12.
Benign intracranial hypertension and recombinant growth hormone therapy in Australia and New Zealand
PA Crock JD McKenzie AM Nicoll NJ Howard W Cutfield LK Shield G Byrne 《Acta paediatrica (Oslo, Norway : 1992)》1998,87(4):381-386
Benign intracranial hypertension (BIH) is reported in three children from Australia and one from New Zealand, who were being treated with recombinant human growth hormone (rhGH). Three males and one female, aged between 10.5 and 14.2 y, developed intracranial hypertension within 2 weeks to 3 months of starting treatment. A national database, OZGROW, has been prospectively collecting data on all 3332 children treated with rhGH in Australia and New Zealand from January 1986 to 1996. The incidence of BIH in children treated with growth hormone (GH) is small, 1.2 per 1000 cases overall, but appears to be greater with biochemical GHD (<10IUml -1 ), i.e. 6.5/1000 (3 in 465 cases), relative risk 18.4, 95% confidence interval 1.9-176.1, than in all other children on the database. The incidence in patients with Turner's syndrome was 2.3/1000 (1 in 428 cases). No cases in patients with partial GHD (10–20 IUml -1 ) or chronic renal failure were identified. Possible causative mechanisms are discussed. The authors'practice is now to start GH replacement at less than the usual recommended dose of 14IUm-2 week-1 in those children considered to be at high risk of developing BIH. Ophthalmological evaluation is recommended for children before and during the first few months following commencement of rhGH therapy and is mandatory in the event of peripheral or facial oedema, persistent headaches, vomiting or visual symptoms. The absence of papilledema does not exclude the diagnosis. 相似文献
13.
Dr. D. Byron May Pharm.D.M Dr. Richard H. Drew M.S. Dr. Kimberly C. Yedinak Pharm.D. Dr. John A. Bartlett M.D. 《Pharmacotherapy》1994,14(5):509-513
Study Objective . To investigate the effect of simultaneously administered didanosine (ddI) on the absorption of a single dose of itraconazole. Design . Randomized, crossover, unblinded single-dose pharmacokinetic study in healthy volunteers. Comparisons of itraconazole alone and itraconazole with simultaneous ddI were performed on days 1 and 15. Setting . A university medical center. Patients . Seven healthy men and women. Six subjects (86%) completed the study; one was removed due to the development of a rash. Interventions . Volunteers received a single 200-mg oral dose of itraconazole or itraconazole with concomitant oral ddI 300 mg (two 150-mg tablets) dispersed in 240 ml water. Each regimen was separated by a 2-week washout period. Serum samples were obtained frequently for 12 hours after the dose. Measurements and Main Results . Concentrations of itraconazole were determined using a microbiologic assay. Individual concentrations in serum versus time data were evaluated by linear regression analysis. Peak serum concentration and time to peak were determined by visual inspection of each individual's serum concentration-time curve. A mean ± SD peak serum itraconazole concentration of 0.90 ± 0.30 μg/ml was observed at 3.0 ± 0.7 hours when itraconazole was administered alone, compared with undetectable levels in all patients during therapy with ddI. Conclusions . Simultaneous oral administration of ddI significantly decreases absorption of itraconazole. These drugs should not be administered concurrently. 相似文献
14.
Milton J. Guiberteau MD Pamela A. Wilcox RN MBA Sandra Bjork RN JD 《Journal of the American College of Radiology》2004,1(2):92-97
Clinical practice guidelines have emerged as a reality for medical practitioners over the past 20 years. Although virtually all groups interested in the development of practice guidelines hope for improvements in patient care, secondary expectations vary widely among those using them. Their use in daily practice by physicians has met with resistance from barriers including concerns of “cookbook” medicine, a loss of autonomy, and increased professional liability. The recent experience of the ACR in addressing these challenges illustrates that physicians are receptive to steps perceived to mitigate the risks accompanying the use of guidelines as well as to efforts to increase their understanding of implementing guidelines in clinical practice. The experiences of other medical societies and an inventory of future trends reveal additional challenges associated with the use of practice guidelines, as third parties look to guidelines as points of reference for gauging the performance of health care providers. 相似文献
15.
目的由于卒中风险随着狭窄严重程度的增加而升高,因此认为颈内动脉(ICA)接近闭塞患者的卒中风险很高。在现有的随机试验中,还没有专门针对这种情况进行探讨,因此其处理尚存在争汶。方法:对相关文献进行系统评价。结果:对ICA接近闭塞患者的处理还存在争议:一些学者支持进行干预,而另一些学者则认为存在风险或没有益处而反对进行干预。在ICA接近闭塞的有症状患者中进行一项比较外科治疗与最佳内科治疗的多中心前瞻性随机试验似乎非常困难,因为这类研究需要大量的患者。尽管如此,基于目前的证据,似乎很难拒绝手术治疗。结论:由于目前对ICA接近闭塞患者的最佳处理方案仍存在着争议,因此需要前瞻性观察性研究以证实其在有症状和无症状人群中的患病率以及相关的卒中风险。基于目前的证据,大多数医疗中心选择手术治疗,但它相对干内科治疗的特粱尚右待证章. 相似文献
16.
17.
H L Anderson R J Attorri J R Custer R A Chapman R H Bartlett 《The Journal of thoracic and cardiovascular surgery》1990,99(6):1011-9; discussion 1019-21
Extracorporeal membrane oxygenation is now standard treatment of severe respiratory failure in newborn infants in our center (200 cases) and worldwide (over 2500 cases), but there are few reports of such trials in older children. We reviewed our experience with extracorporeal membrane oxygenation in 33 children aged 1 week to 18 years between 1971 and 1989. The modality was used when all other treatment failed. Extracorporeal membrane oxygenation provided excellent cardiopulmonary support for 1 to 25 days (average 7 1/2 days). The survival rate was 25% for cardiac support patients and 47% for respiratory failure patients (36% overall survival). Mechanical complications included membrane lung failure, tubing rupture, and pump failure, all managed without mortality. Physiologic complications included bleeding, pneumothorax, cardiac arrest, renal failure, hepatic failure, and brain injury. The major cause of death was irreversible injury to lung, heart, or brain. Extracorporeal life support is a reasonable approach for children with serious but reversible cardiopulmonary failure. 相似文献
18.
19.
20.